Taiwan
· Delayed Price · Currency is TWD Microbio Statistics
Total Valuation
Microbio has a market cap or net worth of TWD 23.09 billion. The enterprise value is 21.85 billion.
| Market Cap | 23.09B |
| Enterprise Value | 21.85B |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Microbio has 588.17 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Shares Outstanding | 588.17M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 7.27% |
| Float | 431.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.94 |
| PB Ratio | 2.05 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -22.42 |
| EV / Sales | 13.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -204.39 |
Financial Position
The company has a current ratio of 8.24, with a Debt / Equity ratio of 0.05.
| Current Ratio | 8.24 |
| Quick Ratio | 7.65 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.86 |
| Interest Coverage | -30.87 |
Financial Efficiency
Return on equity (ROE) is -9.00% and return on invested capital (ROIC) is -1.29%.
| Return on Equity (ROE) | -9.00% |
| Return on Assets (ROA) | -1.24% |
| Return on Capital (ROIC) | -1.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 5.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.72% in the last 52 weeks. The beta is 1.37, so Microbio's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -15.72% |
| 50-Day Moving Average | 40.06 |
| 200-Day Moving Average | 41.33 |
| Relative Strength Index (RSI) | 39.01 |
| Average Volume (20 Days) | 1,046,241 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Microbio had revenue of TWD 1.66 billion and -974.50 million in losses. Loss per share was -1.66.
| Revenue | 1.66B |
| Gross Profit | 631.15M |
| Operating Income | -281.23M |
| Pretax Income | -1.17B |
| Net Income | -974.50M |
| EBITDA | -182.24M |
| EBIT | -281.23M |
| Loss Per Share | -1.66 |
Balance Sheet
The company has 3.50 billion in cash and 626.37 million in debt, giving a net cash position of 2.87 billion or 4.89 per share.
| Cash & Cash Equivalents | 3.50B |
| Total Debt | 626.37M |
| Net Cash | 2.87B |
| Net Cash Per Share | 4.89 |
| Equity (Book Value) | 12.89B |
| Book Value Per Share | 19.13 |
| Working Capital | 3.39B |
Cash Flow
In the last 12 months, operating cash flow was -61.94 million and capital expenditures -44.94 million, giving a free cash flow of -106.88 million.
| Operating Cash Flow | -61.94M |
| Capital Expenditures | -44.94M |
| Free Cash Flow | -106.88M |
| FCF Per Share | -0.18 |
Margins
Gross margin is 38.10%, with operating and profit margins of -16.98% and -58.83%.
| Gross Margin | 38.10% |
| Operating Margin | -16.98% |
| Pretax Margin | -70.92% |
| Profit Margin | -58.83% |
| EBITDA Margin | -11.00% |
| EBIT Margin | -16.98% |
| FCF Margin | -6.45% |
Dividends & Yields
Microbio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | -4.22% |
| FCF Yield | -0.46% |
Stock Splits
The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.
| Last Split Date | Aug 29, 2024 |
| Split Type | Forward |
| Split Ratio | 1.049999998 |
Scores
Microbio has an Altman Z-Score of 13.55.
| Altman Z-Score | 13.55 |
| Piotroski F-Score | n/a |